의료용 멤브레인 시장 보고서 : 기술별, 재료별, 용도별, 지역별(2025-2033년)

The global medical membrane market size reached USD 4.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.1 Billion by 2033, exhibiting a growth rate (CAGR) of 7.15% during 2025-2033.

Medical membrane refers to a technology utilized in drug delivery, tissue regeneration, artificial organs, and diagnostic devices. It assists in processing products with high purity and the concentration, separation and purification of various medical processes. It also aids in the treatment of patients suffering from various pathologies by removing toxins from the blood. It is used as a selective barrier to keep immune system components from encountering implants while allowing nutrients and metabolites to permeate the cells freely. As a result, it finds applications in hospitals, ambulatory centers, clinics, and community healthcare centers around the world.

Medical Membrane Market Trends:

There is currently a rise in the prevalence of chronic diseases like renal failure, diabetes, and atherosclerosis across the globe. This, along with the growing utilization of medical membrane in dialysis for filtration and blood purification, represents one of the key factors driving the market. Moreover, there is an increase in the employment of medical membranes in the recovery of concentrated proteins and enzymes. This, coupled with the rising awareness among individuals about the benefits of the medical membrane, is propelling the growth of the market. In addition, the escalating demand for medical membrane devices, such as microfiltration, intravenous (IV) infusion filters and sterile filtration, for curing various diseases is offering lucrative growth opportunities to industry investors. Besides this, the growing need for artificial organ implants due to organ failure is positively influencing the market. Apart from this, rising applications of ultra-pure water for manufacturing pharmaceutical products are catalyzing the demand for medical membranes. Additionally, the escalating demand for medical membrane in wastewater treatment as it has a higher selectivity towards critical components is bolstering the growth of the market.

Key Market Segmentation:

Breakup by Technology:

• Microfiltration
• Ultrafiltration
• Nanofiltration
• Dialysis
• Gas Filtration
• Others

Breakup by Material:

• Acrylics
• Polypropylene (PP)
• Polyvinylidene Fluoride (PVDF)
• Polysulfone (PSU) and Polyether Sulfone (PESU)
• Polytetrafluoroethylene (PTFE)
• Others

Breakup by Application:

• Pharmaceutical Filtration
• IV Infusion and Sterile Filtration
• Bio-Artificial Processes
• Drug Delivery
• Hemodialysis
• Others

Breakup by Region:

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation), Hangzhou Cobetter Filtration Equipment Co. Ltd., Koch Separation Solutions (Koch Engineered Solutions), Medtronic plc, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Thermo Fisher Scientific and W. L. Gore & Associates Inc.

Key Questions Answered in This Report

• 1.What was the size of the global medical membrane market in 2024?
• 2.What is the expected growth rate of the global medical membrane market during 2025-2033?
• 3.What has been the impact of COVID-19 on the global medical membrane market?
• 4.What are the key factors driving the global medical membrane market?
• 5.What is the breakup of the global medical membrane market based on technology?
• 6.What is the breakup of the global medical membrane market based on the material?
• 7.What is the breakup of the global medical membrane market based on the application?
• 8.What are the key regions in the global medical membrane market?
• 9.Who are the key players/companies in the global medical membrane market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Medical Membrane Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Technology

• 6.1 Microfiltration
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Ultrafiltration
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Nanofiltration
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Dialysis
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 Gas Filtration
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Others
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast

7 Market Breakup by Material

• 7.1 Acrylics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Polypropylene (PP)
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Polyvinylidene Fluoride (PVDF)
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Polysulfone (PSU) and Polyether Sulfone (PESU)
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast
• 7.5 Polytetrafluoroethylene (PTFE)
  • 7.5.1 Market Trends
  • 7.5.2 Market Forecast
• 7.6 Others
  • 7.6.1 Market Trends
  • 7.6.2 Market Forecast

8 Market Breakup by Application

• 8.1 Pharmaceutical Filtration
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 IV Infusion and Sterile Filtration
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Bio-Artificial Processes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Drug Delivery
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Hemodialysis
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast
• 8.6 Others
  • 8.6.1 Market Trends
  • 8.6.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 3M Company
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Asahi Kasei Medical Co. Ltd. (Asahi Kasei Corporation)
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
  • 14.3.3 Hangzhou Cobetter Filtration Equipment Co. Ltd.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
  • 14.3.4 Koch Separation Solutions (Koch Engineered Solutions)
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 SWOT Analysis
  • 14.3.5 Medtronic plc
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Merck KGaA
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
    • 14.3.6.4 SWOT Analysis
  • 14.3.7 Pall Corporation (Danaher Corporation)
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 SWOT Analysis
  • 14.3.8 Sartorius AG
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 Thermo Fisher Scientific
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 W. L. Gore & Associates Inc.
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
    • 14.3.10.3 SWOT Analysis